報價延遲最少15分鐘:2024/06/01 06:27 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
1.44 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-2.00/-1.64
|
|
企業價值
14.86M
|
| 資產負債 |
|
每股賬面淨值
0.90
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
0
|
|
每股收益
0.03
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2024/06/01 06:27 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Imunon Inc is developing new medicines that harness the building blocks of life to work in harmony with the body's immune system. It is a fully integrated, clinical-stage biotechnology company focused on advancing a portfolio of treatmentsthat harness the body's natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. |